N8-GP: A new extended half-life recombinant factor VIII product for hemophilia A

被引:2
|
作者
Chowdary, Pratima [1 ]
机构
[1] Royal Free Hosp, Katharine Dormandy Haemophilia & Thrombosis Ctr, Pond St, London NW3 2QG, England
关键词
D O I
10.1111/jth.14966
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3 / 4
页数:2
相关论文
共 50 条
  • [41] Bleeding patterns evaluated during prophylaxis with a full-length pegylated recombinant factor VIII (bax 855) with extended half-life in hemophilia A
    Konkle, B.
    Stasyshn, O.
    Wynn, T.
    Manco-Johnson, M.
    Gruppo, R.
    Chowdary, P.
    Komrska, V
    Griskevicius, L.
    Eyster, M. E.
    Chojnowski, K.
    Engl, W.
    Patrone, L.
    Abbuehl, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 356 - 357
  • [42] Comparison of Real-World Dose and Consumption for Two Extended Half-Life Recombinant Factor VIII Products for the Treatment of Hemophilia A in the United States
    Wu, Yanyu
    Sun, Shawn X.
    Fan, Tao
    JOURNAL OF BLOOD MEDICINE, 2022, 13 : 517 - 524
  • [43] Comment on "Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Insights from Pivotal and Extension Studies"
    Horneff, Regina
    Bystricka, Linda
    Santagostino, Elena
    Lethagen, Stefan
    Casiano, Sandra
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2022, 48 (02): : 251 - 252
  • [44] Factor VIII-Fc Fusion Protein Shows Extended Half-Life and Hemostatic Activity in Hemophilia A Dogs
    Dumont, Jennifer A.
    Kamphaus, George D.
    Fraley, Cara
    Ashworth, Tamera
    Franck, Helen
    Merricks, Elizabeth P.
    Nichols, Timothy C.
    Bitonti, Alan J.
    BLOOD, 2009, 114 (22) : 228 - 228
  • [45] Limited sampling strategies for accurate determination of extended half-life factor VIII pharmacokinetics in severe hemophilia A patients
    Goggans, Margaret H.
    Barker, Patricia J.
    Jacobs, Timothy W.
    Neufeld, Ellis J.
    Reiss, Ulrike M.
    Panetta, John C.
    McEneny-King, Alanna
    HAEMOPHILIA, 2018, 24 : 89 - 89
  • [46] PK-guided switch from standard half-life to extended half-life factor VIII products
    Eduardo Megias-Vericat, Juan
    Bonanad, Santiago
    Martinez Garcia, Maria Fernanda
    Berrueco Moreno, Ruben
    Maria Mingot-Castellano, Eva
    Rodriguez Lopez, Manuel
    Canaro Hirnyk, Mariana
    Mateo Arranz, Jose
    Calvo Villas, Jose Manuel
    Haya, Saturnino
    Rosa Cid, Ana
    Iorio, Alfonso
    HAEMOPHILIA, 2020, 26 : 17 - 18
  • [47] PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTS
    Megias Vericat, J. E.
    Bonanad-Boix, S.
    Martinez Garcia, M. F.
    Berrueco, R.
    Mingot-Castellano, M. E.
    Rodriguez, M.
    Canaro, M.
    Mateu, J.
    Larrode, I.
    Haya, S.
    Santamaria, A.
    Mesegue, M.
    Albo, C.
    Palomero, A.
    Vilalta, N.
    Calvo, J. M.
    Cid, A. R.
    Poveda, J. L.
    Iorio, A.
    HAEMOPHILIA, 2020, 26 : 88 - 89
  • [48] Extended half-life factor VIII for immune tolerance induction in haemophilia
    Malec, L. M.
    Journeycake, J.
    Ragni, M. V.
    HAEMOPHILIA, 2016, 22 (06) : E552 - E554
  • [49] Recovery and half-life of factor VIII
    Koc, Basak
    Zulfikar, Bulent
    Ozcan, Hanife
    HAEMOPHILIA, 2014, 20 : 52 - 53
  • [50] Extended half-life factor
    Smith, Lan-Lan
    LANCET HAEMATOLOGY, 2020, 7 (09): : E636 - E636